Treating Psoriasis as a T-Cell Mediated Disease
More like this
- Phase 3 Clinical Trials Support STELARA® (ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
- Considerations for the Clinical Assessment of the Patient With Plaque Psoriasis
- Unmet Needs in the Management of Plaque Psoriasis
- Managed Care Best Practices In the Treatment and Management of Psoriasis
- The 'Heartbreak of Psoriasis' Has Met Its Match!